Go to main content

  1. Home
  2. Serious Bacterial Infections

Global Antibiotic Research and Development Partnership

Serious Bacterial Infections

Disclaimer: The data for this page has been produced from IATI data published by Global Antibiotic Research and Development Partnership. Please contact them (Show Email Address) if you have any questions about their data.

Programme Data Last Updated: 29/10/2021

IATI Identifier: CH-FDJP-CHE331930936-SBI-20

Description

Serious bacterial infections are a major cause of death in hospitals and healthcare settings. Bacteria can enter the body through wounds and surgery sites, ventilators and catheters, leading to pneumonia, urinary tract, abdominal and bloodstream infections. The Global Antibiotic Research and Development Partnership (GARDP) is working to develop new treatments for these serious bacterial infections, focusing on treatments for drug-resistant bacteria on the World Health Organization’s (WHO) priority pathogens list.

Status - Implementation More information about Programme status
Programme Spend More information about Programme funding
Implementing Organisation(s) More information about implementing organisation(s)
  • Global Antibiotic Research and Development Partnership

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more